CD19-Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma

Conditions:   Leukemia;   Lymphoma, Large B-Cell, Diffuse;   Leukemia, B-cell;   Lymphoma, B-Cell;   Leukemia, Lymphocytic, Chronic, B-Cell Intervention:   Biological: CD19 CAR-T cells Sponsor:   Chongqing Precision Biotech Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials